Radioiodine therapy for papillary and follicular thyroid carcinoma

Michele Klain; Marcel Ricard; Sophie Leboulleux; Eric Baudin; Martin Schlumberger

doi:10.1007/s00259-002-0810-9

Radioiodine therapy for papillary and follicular thyroid carcinoma

Michele Klain, Marcel Ricard, Sophie Leboulleux, Eric Baudin, Martin Schlumberger

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

50 Citations (Scopus)

Résumé

Radioiodine (¹³¹I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease. It should be used selectively, i.e. only in those patients for whom a clinical benefit may be expected.

langue originale	Anglais
Pages (de - à)	S479-S485
journal	European Journal of Nuclear Medicine
Volume	29
Les DOIs	https://doi.org/10.1007/s00259-002-0810-9
état	Publié - 1 janv. 2002

Accès au document

10.1007/s00259-002-0810-9

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{0984dbe41c0a4127823cc907a0a76a65,

title = "Radioiodine therapy for papillary and follicular thyroid carcinoma",

abstract = "Radioiodine (131I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease. It should be used selectively, i.e. only in those patients for whom a clinical benefit may be expected.",

keywords = "Ablation, Metastases, Radioiodine, Thyroid carcinoma",

author = "Michele Klain and Marcel Ricard and Sophie Leboulleux and Eric Baudin and Martin Schlumberger",

year = "2002",

month = jan,

day = "1",

doi = "10.1007/s00259-002-0810-9",

language = "English",

volume = "29",

pages = "S479--S485",

journal = "European Journal of Nuclear Medicine",

issn = "0340-6997",

}

TY - JOUR

T1 - Radioiodine therapy for papillary and follicular thyroid carcinoma

AU - Klain, Michele

AU - Ricard, Marcel

AU - Leboulleux, Sophie

AU - Baudin, Eric

AU - Schlumberger, Martin

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Radioiodine (131I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease. It should be used selectively, i.e. only in those patients for whom a clinical benefit may be expected.

AB - Radioiodine (131I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease. It should be used selectively, i.e. only in those patients for whom a clinical benefit may be expected.

KW - Ablation

KW - Metastases

KW - Radioiodine

KW - Thyroid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0036373149&partnerID=8YFLogxK

U2 - 10.1007/s00259-002-0810-9

DO - 10.1007/s00259-002-0810-9

M3 - Review article

C2 - 12192549

AN - SCOPUS:0036373149

SN - 0340-6997

VL - 29

SP - S479-S485

JO - European Journal of Nuclear Medicine

JF - European Journal of Nuclear Medicine

ER -